遇见数据集

Additional file 1: of Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma

收藏
NIAID Data Ecosystem2026-03-09 收录
二维码
社区交流群
二维码
科研交流群
商业服务